These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21135602)

  • 41. Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation.
    Conde D; Costabel JP; Caro M; Ferro A; Lambardi F; Corrales Barboza A; Lavalle Cobo A; Trivi M
    Int J Cardiol; 2013 Oct; 168(3):2423-5. PubMed ID: 23518212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vernakalant hydrochloride for the treatment of atrial fibrillation: evaluation of its place in clinical practice.
    Ritchie LA; Qin S; Penson PE; Henney NC; Lip GY
    Future Cardiol; 2020 Nov; 16(6):585-595. PubMed ID: 32460637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial.
    Kowey PR; Dorian P; Mitchell LB; Pratt CM; Roy D; Schwartz PJ; Sadowski J; Sobczyk D; Bochenek A; Toft E;
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):652-9. PubMed ID: 19948506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial.
    Camm AJ; Toft E; Torp-Pedersen C; Vijayaraman P; Juul-Moller S; Ip J; Beatch GN; Dickinson G; Wyse DG;
    Europace; 2012 Jun; 14(6):804-9. PubMed ID: 22291438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systematic Review and Meta-analysis Appraising Efficacy and Safety of Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation.
    Ma W; Guo X; Wang Q; Sun G; Wang J
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):32-41. PubMed ID: 32251022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
    Camm AJ; Capucci A; Hohnloser SH; Torp-Pedersen C; Van Gelder IC; Mangal B; Beatch G;
    J Am Coll Cardiol; 2011 Jan; 57(3):313-21. PubMed ID: 21232669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of intravenous vernakalant for atrial fibrillation conversion in the regular ward under only bedside monitoring.
    Manolis AS; Bethanis S; Metaxa S; Polytarchou K; Sakellaris N; Pyrros I
    Hellenic J Cardiol; 2019; 60(1):54-56. PubMed ID: 29454598
    [No Abstract]   [Full Text] [Related]  

  • 48. Predictors of conversion of recent-onset atrial fibrillation treated with vernakalant.
    Costabel JP; Lambardi F; Aragón M; Campos R; Urdapilleta M; Ariznavarreta P; Vergara JM; Conde D
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):196-200. PubMed ID: 25469647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vernakalant: conversion of atrial fibrillation in patients with ischemic heart disease.
    Torp-Pedersen C; Camm AJ; Butterfield NN; Dickinson G; Beatch GN
    Int J Cardiol; 2013 Jun; 166(1):147-51. PubMed ID: 22108512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New anthyarrhythmic drugs for atrial fibrillation.
    Matassini MV; Guerra F; Scappini L; Urbinati A; Capucci A
    Future Cardiol; 2015; 11(6):705-17. PubMed ID: 26631497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation.
    Pohjantähti-Maaroos H; Hyppölä H; Lekkala M; Sinisalo E; Heikkola A; Hartikainen J
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):114-120. PubMed ID: 28849946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Vernakalant in hospital emergency practice: safety and effectiveness].
    Carbajosa Dalmau J; Cosín-Sales J; Pérez-Durá MJ; Noceda J; Urtubia-Palacios A; Hernández-Sori N; Peiró-Gómez A; Jacob J; Llorens P; Ruescas-Gómez L; Martín-Martínez A
    Emergencias; 2017 Dic; 29(6):397-402. PubMed ID: 29188914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementing vernakalant: a novel approach to cardioversion.
    Hall A
    Emerg Nurse; 2018 Dec; 27(1):14-20. PubMed ID: 30550052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of vernakalant and ranolazine in atrial fibrillation.
    Frommeyer G; Sterneberg M; Dechering DG; Kochhäuser S; Bögeholz N; Fehr M; Eckardt L
    J Cardiovasc Med (Hagerstown); 2017 Sep; 18(9):663-668. PubMed ID: 28692548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of pharmacological cardioversion of atrial fibrillation using intravenous vernakalant, a new antiarrhythmic drug with atrial selectivity.
    Blomström-Lundqvist C; Blomström P
    Expert Opin Drug Saf; 2012 Jul; 11(4):671-9. PubMed ID: 22632377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vernakalant for the conversion of atrial fibrillation: the new kid on the block?
    Conde D; Baranchuk A
    Ann Noninvasive Electrocardiol; 2014 Jul; 19(4):299-302. PubMed ID: 24738652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meta-analysis of effect of vernakalant on conversion of atrial fibrillation.
    Yan H; Aung TT; Guoqiang Z; Zhengnan Z; Lan J; Zhiyu Z
    BMC Res Notes; 2013 Mar; 6():94. PubMed ID: 23497611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Real-world Data on the Efficacy of Vernakalant for Pharmacological Cardioversion in Patients With Recent-onset Atrial Fibrillation.
    Cosin-Sales J; Loscos A; Peiró A; Sorando MR; Buendía F; Ruescas L
    Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):619-20. PubMed ID: 27131972
    [No Abstract]   [Full Text] [Related]  

  • 59. Recent-onset atrial fibrillation in patients with left ventricular dysfunction: amiodarone or vernakalant?
    Conde D; Costabel JP; Alves de Lima A
    Can J Cardiol; 2013 Oct; 29(10):1330.e11-1330.e12. PubMed ID: 23639270
    [No Abstract]   [Full Text] [Related]  

  • 60. Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.
    Bash LD; Buono JL; Davies GM; Martin A; Fahrbach K; Phatak H; Avetisyan R; Mwamburi M
    Cardiovasc Drugs Ther; 2012 Apr; 26(2):167-79. PubMed ID: 22418856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.